PANPHARMA NORDIC AS

1400 SKI

Finances

Share Ownership

Return on Equity

13,29 %

Current Ratio

1,25

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	39 822 000	23 660 000	34 819 000	21 090 000
Net Income	568 000	603 000	816 000	3 529 000
Total Assets	21 326 000	17 757 000	15 880 000	12 024 000
Total Equity	4 273 000	3 705 000	3 102 000	2 287 000

Income (NOK)	2022	2021	2020	2019
Revenue	39 822 000	23 660 000	34 819 000	21 090 000
Expenditure	38 115 000	22 160 000	32 625 000	16 720 000
Operating Profit	1 708 000	1 500 000	2 193 000	4 369 000
Financial Income	341 000	506 000	743 000	75 000
Financial Costs	1 321 000	1 233 000	1 890 000	278 000
Financial Balance	−980 000	−727 000	−1 147 000	−203 000
Earnings Before Tax	728 000	773 000	1 047 000	4 165 000
Tax	160 000	170 000	231 000	637 000
Net Income	568 000	603 000	816 000	3 529 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	43 000	55 000	19 000	31 000
Total Current Assets	21 283 000	17 702 000	15 861 000	11 994 000
Total Assets	21 326 000	17 757 000	15 880 000	12 024 000
Total Retained Equity	4 243 000	3 675 000	3 072 000	2 257 000
Total Equity	4 273 000	3 705 000	3 102 000	2 287 000
Total Long-Term Debt	6 000	4 000	4 000	0
Total Current Debt	17 047 000	14 048 000	12 773 000	9 737 000
Total Equity and Debt	21 326 000	17 757 000	15 880 000	12 024 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	39 822 000	23 660 000	34 819 000	21 090 000
Other Income	0	0	0	0
Revenue	39 822 000	23 660 000	34 819 000	21 090 000
Cost of Goods Sold	30 842 000	16 609 000	26 733 000	11 945 000
Salary Costs	2 456 000	2 191 000	1 734 000	1 545 000
Depreciation	12 000	12 000	6 000	6 000
Impairment	0	0	0	0
Expenditure	38 115 000	22 160 000	32 625 000	16 720 000
Operating Profit	1 708 000	1 500 000	2 193 000	4 369 000
Financial Income	341 000	506 000	743 000	75 000
Financial Costs	1 321 000	1 233 000	1 890 000	278 000
Financial Balance	−980 000	−727 000	−1 147 000	−203 000
Dividends	0	0	0	0
Net Income	568 000	603 000	816 000	3 529 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	5 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	42 000	54 000	18 000	24 000
Total Tangible Assets	42 000	54 000	18 000	24 000
Total Fiancial Fixed Assets	1 000	1 000	1 000	1 000
Total Fixed Assets	43 000	55 000	19 000	31 000
Stock	5 049 000	11 042 000	6 252 000	5 308 000
Total Investments	0	0	0	0
Cash, Bank	4 500 000	1 643 000	3 992 000	1 826 000
Total Current Assets	21 283 000	17 702 000	15 861 000	11 994 000
Total Assets	21 326 000	17 757 000	15 880 000	12 024 000
Total Equity	4 273 000	3 705 000	3 102 000	2 287 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	6 000	4 000	4 000	0
Creditors	14 315 000	12 562 000	11 153 000	7 825 000
Unpaid Taxes	2 176 000	894 000	1 047 000	860 000
Dividends	0	0	0	0
Other Current Debt	397 000	421 000	351 000	410 000
Total Current Debt	17 047 000	14 048 000	12 773 000	9 737 000
Total Equity and Debt	21 326 000	17 757 000	15 880 000	12 024 000

Financial indicators	2022	2021	2020	2019
Return on Equity	13,29 %	16,28 %	26,31 %	154,31 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	4,29 %	6,34 %	6,3 %	20,72 %
Current Ratio	1,25	1,26	1,24	1,23
Quick Ratio	1,77	5,89	2,43	2,71
Equity Ratio	0,2	0,21	0,2	0,19
Gross Profit Margin	22,55 %	29,8 %	23,22 %	43,36 %